Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Assets (2019 - 2025)

Historic Assets for Bolt Biotherapeutics (BOLT) over the last 7 years, with Q3 2025 value amounting to $65.1 million.

  • Bolt Biotherapeutics' Assets fell 4050.07% to $65.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.1 million, marking a year-over-year decrease of 4050.07%. This contributed to the annual value of $99.6 million for FY2024, which is 3764.58% down from last year.
  • Bolt Biotherapeutics' Assets amounted to $65.1 million in Q3 2025, which was down 4050.07% from $75.5 million recorded in Q2 2025.
  • Bolt Biotherapeutics' Assets' 5-year high stood at $347.1 million during Q2 2021, with a 5-year trough of $65.1 million in Q3 2025.
  • Over the past 5 years, Bolt Biotherapeutics' median Assets value was $190.7 million (recorded in 2023), while the average stood at $198.1 million.
  • Per our database at Business Quant, Bolt Biotherapeutics' Assets soared by 56116.2% in 2021 and then tumbled by 4050.07% in 2025.
  • Quarter analysis of 5 years shows Bolt Biotherapeutics' Assets stood at $307.7 million in 2021, then fell by 25.97% to $227.8 million in 2022, then fell by 29.86% to $159.8 million in 2023, then tumbled by 37.65% to $99.6 million in 2024, then tumbled by 34.71% to $65.1 million in 2025.
  • Its Assets was $65.1 million in Q3 2025, compared to $75.5 million in Q2 2025 and $85.9 million in Q1 2025.